Characterization of the viral population during primary HIV-1 infection

AIDS

Volumn 12, Issue 8, 1998, Pages 839-847

  Karlsson, Annika C ^a   Lindbäck, Stefan ^a   Gaines, Hans ^a,b   Sönnerborg, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Acute infection; env; gag; Heterogeneity; HIV 1; Molecular biology; Variation

Indexed keywords

GAG PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

BASE SEQUENCE; CLONING, MOLECULAR; FEMALE; GENES, ENV; GENES, GAG; GENETIC HETEROGENEITY; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; VIREMIA;

EID: 0032574895     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199808000-00005     Document Type: Article

References (38)

1. Cooper DA, Gold J, Maclean P, et al.: Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1985, i:537-540.
2. Gaines H, von Sydow M, Pehrson PO, Lundbergh P: Clinical picture of primary HIV infection presenting as a glandularfever-like illness. BMJ 1988, 297:1363-1368.
3. Kinloch-de Loës S, de Saussure P, Saurat J-H, Stalder H, Hirschel B, Perrin LH: Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis 1993, 17:59-65.
4. Daar ES, Moudgil T, Meyer RD, Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991, 324:961-964.
5. Albert J, Abrahamsson B, Nagy K, et al.: Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990, 4:107-112.
6. Safrit JT, Koup RA: The immunology of primary HIV infection: which immune responses control HIV replication? Curr Opin Immunol 1995, 1995:456-461.
7. Mackewicz CE, Yang LC, Lifson JD, Levy JA: Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 1994, 344:1671-1673.
8. Moore JP, Cao Y, Ho DD, Koup RA: Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J Virol 1994, 68:5142-5155.
9. Zaunders J, Carr A, McNally L, Penny R, Cooper DA: Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes. AIDS 1995, 9:561-566.
10. Gaines H, von Sydow M, Sonnerborg A, et al.: Antibody response in primary human immunodeficiency virus infection. Lancet 1987, i:1249-1253.
11. Wolfs TF, Zwart C, Bakker M, Coudsmit J: HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 1992, 189:103-110.
12. Zhu T, Mo H, Wang N, et al.: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261:1179-1181.
13. Zhang LQ, Mackenzie P, Cleland A, Holmes EC, Brown AJ, Simmonds P: Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993, 67:3345-3356.
14. Ait-Khaled M, Emery VC: Sequence variation within the human immunodeficiency virus V3 loop at seroconversion. J Med Virol 1993, 41:270-274.
15. Mulder-Kampinga CA, Simonon A, Dekker CLK, Scherpbier HJ, Van de Perre P, Goudsmit J: Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J Virol 1995, 69:2285-2296.
16. Zhu T, Wang N, Carr A, et al.: Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretion: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996, 70:3098-3107.
17. Poss M, Martin HL, Kreiss JK, et al.: Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J virol 1995, 69:8118-8122.
18. Kampinga GA, Simonon A, van de Perre P, Karita E, Msellati P, Goudsmit J: Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombination of HIV-1 subtypes A and C. Virology 1997, 227:63-76.
19. Pang S, Shlesinger Y, Daar ES, Moudgil T, Ho DD, Chen IY: Rapid generation of sequence variation during primary HIV-1 infection. AIDS 1992, 6:453-460.
20. Albert J, Wahlberg J, Leitner T, Escanilla D, Uhlén M: Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol 1994, 68:5910-5924.
21. Wahlberg J, Lundberg J, Hultman T, Uhlén M: General colorimetric method for DNA diagnostics allowing direct solid-phase genomic sequencing of the positive samples. Proc Natl Acad Sci USA 1990, 87:6569-6573.
22. Odeberg J, Yun Z, Sünnerborg A, Uhlén M, Lundeberg J: Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing. J Clin Microbiol 1995, 33:1870-1874.
23. Larder BA, Kohli A, Kellam P, Kemp SD, Kronick M, Henfrey RD: Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing. Nature 1993, 365:671-673.
24. Leitner T, Halapi E, Scarlatti G, et al: Analysis of heterogeneous viral populations by direct DNA sequencing. BioTechniques 1993, 15:120-127.
25. Yun ZB, Odeberg J, Lundeberg J, Weiland O, Uhlen M, Sonnerborg A: Restriction of hepatitis C virus heterogeneity during prolonged interferon-alpha therapy in relation to changes in virus load. J Infect Dis 1996, 173:992-996.
26. Felsenstein J: PHYLIP (Phylogeny Interference Package) Version 3.5c. Seattle: University of Washington; March 1993.
27. Myers G, Korber B, Hahn BH, et al.: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos: Los Alamos National Laboratory; 1995.
28. Nei M, Gojobori T: Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986, 3:418-426.
29. Kumar S, Tamura K, Nei M: Molecular Evolutionary Genetic Analysis (MEGA), Version 1.01. University Park: Institute of Molecular Evolutionary Genetics, Pennsylvania State University; 1993.
30. Milich L, Margolin B, Swanstrom R: V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J Virol 1993, 67:5623-5634.
31. Fouchier RA, Brouwer M, Broersen SM, Schuitemaker H: Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J Clin Microbiol 1995, 33:906-911.
32. Cornelissen M, Mulder-Kampinga G, Veenstra J, et al.: Syncytium-inducing (SI) phenotype suppression at serocon-version after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol 1995, 69:1810-1818.
33. Okada SI, Akahane Y, Suzuki H, Okamoto H, Mishiro S: The degree of variability in the amino terminal region of the E2/NSI protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992, 16:619-624.
34. Lukashov VV, Goudsmit J: Founder virus population related to route of virus transmission: a determinant of intrahost human immunodeficiency virus type 1 evolution? J Virol 1997, 71:2023-2030.
35. Trichel AM, Roberts ED, Wilson LA, Martin LN, Ruprecht RM, Murphey-Corb M: SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque. J Med Primatol 1997, 26:3-10.
36. Roos MT, Lange JM, de Goede RE, et al: Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 1992, 165:427-432.
37. Nielsen C, Pedersen C, Lundgren JD, Gerstoft J: Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 1993, 7:1035-1040.
38. Simmonds P, Zhang LQ, McOmish F, Balfe P, Ludlam CA, Leigh Brown AJ: Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J Virol 1991, 65:6266-6276.